The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 7
  • 1
    Roser, Bruce Joseph, Dr
    Director born in January 1935
    Individual (2 offsprings)
    Officer
    2012-01-26 ~ now
    OF - director → CIF 0
  • 2
    Tuncer, Ozgur
    Company Director born in December 1977
    Individual (2 offsprings)
    Officer
    2019-11-25 ~ now
    OF - director → CIF 0
  • 3
    Sutton, Jonathan Davenport
    Director born in November 1961
    Individual (4 offsprings)
    Officer
    2023-04-10 ~ now
    OF - director → CIF 0
  • 4
    Goddard, Charlie Paul
    Company Director born in July 1970
    Individual (5 offsprings)
    Officer
    2019-11-25 ~ now
    OF - director → CIF 0
  • 5
    Chatfield, Steven Neville, Dr
    Director born in January 1957
    Individual (8 offsprings)
    Officer
    2024-11-01 ~ now
    OF - director → CIF 0
  • 6
    Child, Nicholas Edward
    Ceo born in March 1961
    Individual (5 offsprings)
    Officer
    2012-06-01 ~ now
    OF - director → CIF 0
  • 7
    Mayall, Neil John
    Company Director born in April 1967
    Individual (5 offsprings)
    Officer
    2019-11-25 ~ now
    OF - director → CIF 0
    Mayall, Neil
    Individual (5 offsprings)
    Officer
    2023-01-26 ~ now
    OF - secretary → CIF 0
Ceased 5
  • 1
    Dr Bruce Joseph Roser
    Born in January 1935
    Individual (2 offsprings)
    Person with significant control
    2016-04-06 ~ 2022-11-30
    PE - Ownership of shares – More than 25% but not more than 50% → CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
  • 2
    Powell, Martin Carrick
    Company Director born in May 1956
    Individual
    Officer
    2013-07-18 ~ 2023-05-01
    OF - director → CIF 0
  • 3
    Shepherd, Robert John
    Company Director born in November 1958
    Individual (1 offspring)
    Officer
    2016-07-01 ~ 2024-02-01
    OF - director → CIF 0
  • 4
    Child, Nicholas Edward
    Individual (5 offsprings)
    Officer
    2012-06-01 ~ 2017-02-22
    OF - secretary → CIF 0
  • 5
    Smith, Nicola Jane
    Individual
    Officer
    2017-02-23 ~ 2023-01-26
    OF - secretary → CIF 0
parent relation
Company in focus

STABLEPHARMA LIMITED

Standard Industrial Classification
21100 - Manufacture Of Basic Pharmaceutical Products
Brief company account
Intangible Assets
159,067 GBP2023-01-31
197,237 GBP2022-01-31
Property, Plant & Equipment
13,448 GBP2023-01-31
14,534 GBP2022-01-31
Fixed Assets - Investments
2,549 GBP2023-01-31
2,549 GBP2022-01-31
Fixed Assets
175,064 GBP2023-01-31
214,320 GBP2022-01-31
Debtors
Current
975,453 GBP2023-01-31
628,831 GBP2022-01-31
Cash at bank and in hand
3,511,105 GBP2023-01-31
1,885,506 GBP2022-01-31
Current Assets
4,486,558 GBP2023-01-31
2,514,337 GBP2022-01-31
Net Current Assets/Liabilities
4,331,723 GBP2023-01-31
2,470,890 GBP2022-01-31
Net Assets/Liabilities
4,506,787 GBP2023-01-31
2,685,210 GBP2022-01-31
Average Number of Employees
82022-02-01 ~ 2023-01-31
82021-02-01 ~ 2022-01-31
Intangible Assets - Gross Cost
Patents/Trademarks/Licences/Concessions
12,658 GBP2023-01-31
9,993 GBP2022-01-31
Development expenditure
85,273 GBP2023-01-31
85,273 GBP2022-01-31
Other
233,790 GBP2023-01-31
221,576 GBP2022-01-31
Intangible Assets - Gross Cost
331,721 GBP2023-01-31
316,842 GBP2022-01-31
Intangible Assets - Accumulated Amortisation & Impairment
Patents/Trademarks/Licences/Concessions
1,556 GBP2023-01-31
311 GBP2022-01-31
Development expenditure
85,273 GBP2023-01-31
56,848 GBP2022-01-31
Intangible Assets - Accumulated Amortisation & Impairment
172,654 GBP2023-01-31
119,605 GBP2022-01-31
Intangible Assets - Increase From Amortisation Charge for Year
Patents/Trademarks/Licences/Concessions
1,245 GBP2022-02-01 ~ 2023-01-31
Development expenditure
28,425 GBP2022-02-01 ~ 2023-01-31
Intangible Assets - Increase From Amortisation Charge for Year
53,049 GBP2022-02-01 ~ 2023-01-31
Intangible Assets
Patents/Trademarks/Licences/Concessions
11,102 GBP2023-01-31
9,682 GBP2022-01-31
Other
147,965 GBP2023-01-31
159,130 GBP2022-01-31
Development expenditure
28,425 GBP2022-01-31
Property, Plant & Equipment - Gross Cost
Tools/Equipment for furniture and fittings
11,579 GBP2023-01-31
7,191 GBP2022-01-31
Other
12,602 GBP2023-01-31
12,602 GBP2022-01-31
Property, Plant & Equipment - Gross Cost
24,181 GBP2023-01-31
19,793 GBP2022-01-31
Property, Plant & Equipment - Disposals
Other
-38,564 GBP2022-02-01 ~ 2023-01-31
Property, Plant & Equipment - Disposals
-38,564 GBP2022-02-01 ~ 2023-01-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Tools/Equipment for furniture and fittings
4,432 GBP2023-01-31
2,108 GBP2022-01-31
Other
6,301 GBP2023-01-31
3,151 GBP2022-01-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
10,733 GBP2023-01-31
5,259 GBP2022-01-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Tools/Equipment for furniture and fittings
2,324 GBP2022-02-01 ~ 2023-01-31
Other
5,488 GBP2022-02-01 ~ 2023-01-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
7,812 GBP2022-02-01 ~ 2023-01-31
Property, Plant & Equipment - Decrease in depreciation and impairment related to disposals
Other
-2,338 GBP2022-02-01 ~ 2023-01-31
Property, Plant & Equipment - Decrease in depreciation and impairment related to disposals
-2,338 GBP2022-02-01 ~ 2023-01-31
Property, Plant & Equipment
Tools/Equipment for furniture and fittings
7,147 GBP2023-01-31
5,083 GBP2022-01-31
Other
6,301 GBP2023-01-31
9,451 GBP2022-01-31
Investments in Subsidiaries
2,549 GBP2023-01-31
2,549 GBP2022-01-31
Amounts Owed By Related Parties
38,564 GBP2023-01-31
Prepayments
3,901 GBP2023-01-31
31,734 GBP2022-01-31
Other Debtors
932,988 GBP2023-01-31
597,097 GBP2022-01-31
Trade Creditors/Trade Payables
47,371 GBP2023-01-31
17,058 GBP2022-01-31
Taxation/Social Security Payable
23,127 GBP2023-01-31
15,139 GBP2022-01-31
Other Creditors
4,881 GBP2023-01-31
Accrued Liabilities
79,456 GBP2023-01-31
11,250 GBP2022-01-31
Par Value of Share
Class 1 ordinary share
0.00012022-02-01 ~ 2023-01-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
87,117,841 shares2023-01-31
78,427,012 shares2022-01-31
  • STABLEPHARMA LIMITED
    Info
    Registered number 07925414
    Ground Floor, 90 Victoria Street, Bristol BS1 6DP
    Private Limited Company incorporated on 2012-01-26 (13 years 4 months). The company status is Active.
    The last date of confirmation statement was made at 2024-06-28
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.

qrcode

Privacy policy

© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.